VANCOUVER, BC--(Marketwire - February 06, 2008) - Upstream Biosciences Inc. (OTCBB: UPBS) today announced that in vitro data indicates that the company's novel anti-malaria drug candidates have demonstrated encouraging signs of efficacy against malaria. According to the World Health Organization (WHO), an estimated 500 million people become severely ill with malaria and more than one million people die of the disease each year.
